Professor Jan Holgersson
NovaHep was founded in 2005 on the basis of research conducted at the Huddinge unit of the Karolinska Institute in Stockholm. The company is now based in Gothenburg, Sweden, at the Biotech Center.
NovaHep is active within the field of regenerative medicine, developing stem cell technology with a wide range of applications.
The main area of focus is the production of biological, individualised vessels, in collaboration with the University of Gothenburg. The vessels can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The product is unique and patented. Through an improved alternative to traditional treatments, NovaHep will deliver a life changing impact to patients and provide for major benefits for hospitals, healthcare providers and society – globally.
NovaHep also works with liver stem cells for the purpose of developing a system in which drugs can be tested without the use of laboratory animals.
NovaHep AB
Chairman Of The Board
Kerstin Jakobsson
At Medicon Village we want to create an environment where research, innovation and entrepreneurship work together to create value for people’s health and wellbeing. Together with the medical research centres Biomedical Centre (BMC) in Lund and the Clinical Research Centre (CRC) in Malmö, as well as the developing research facilities ESS and the MAX IV laboratory, Medicon Village is establishing an infrastructure of world class and thus providing a huge lift to, and enhancing the attractiveness of, the entire region. The total area available for letting within Medicon Village amounts to around 80,000 m2, of which laboratories account for about 30,000 m2. It is estimated that activities involving the employment of around 500 persons will be established within the facility during the initial phase. Later on, when the plan has been fully executed, more than 1,000 persons will be involved in the activities at Medicon Village.
Medicon Village
Vice President BD
Dr Gavin Jeffries
The Multifunctional pipette is tool for fast localized solution delivery for bioscientists.
It is comprised of a pneumatic control unit, an interfacing holder and the disposable pipette.
In combination with conventional micromanipulation apparatus, a small 100 micron virtual flow chamber can be free positioned within a sample.
Utilizing hydrodynamic confinement, the delivered solution can be localized and rapidly switched without contaminating the sample; enabling large numbers of experiments and parameters to be screened on a single sample dish.
Automation and screening can be achieved through scripting protocols.
Labview and Matlab libraries are now available.
Avalance Biotech AB
COO
Professor Aldo Jesorka
The Multifunctional pipette is tool for fast localized solution delivery for bioscientists.
It is comprised of a pneumatic control unit, an interfacing holder and the disposable pipette.
In combination with conventional micromanipulation apparatus, a small 100 micron virtual flow chamber can be free positioned within a sample.
Utilizing hydrodynamic confinement, the delivered solution can be localized and rapidly switched without contaminating the sample; enabling large numbers of experiments and parameters to be screened on a single sample dish.
Automation and screening can be achieved through scripting protocols.
Labview and Matlab libraries are now available.
Avalance Biotech AB
Scientific advisor
Dr Fred Kjellson
ClinTrials Skåne is a public limited company dedicated to helping the life science industry developing their products in close cooperation with universities and the public health care sector in the county of Skåne. We have long experience in working with clinical trials and product development in hospitals in Skåne. Our offices are located in Skåne university hospital and in Medicon Village in Lund, with direct access to both the life science industry and the public healthcare system.
ClinTrials Skåne AB
Project manager
Carl Otto Lange
We are a Nordic law firm with a simple business concept : to create value for you. This is the guiding principle in everything we do. This means that we always look for solutions which not only comply with the law, but which also generate commercial advantages. It also means that it's not enough for us to obtain results. We want good results. Irrespective of the industry. Irrespective of which Nordic country is involved. Cross-border.
The business operations conducted within life science companies often involve major risks and opportunities for significant earnings. The risks come not only from the advanced scientific and supervisory environment but also from complicated business models. A key to success is for companies to be able to handle these risks. This demands that the contracts which are produced exhaustively govern all of the risks and that these risks are appropriately allocated between the parties.
NORDIA has a practice group with lawyers experienced in life science to assist national and international companies in the area, both listed companies and private companies.
Responsive Web Design powered by 